Page 94 - 80_01
P. 94

José	
  María	
  Rojo,	
  Pilar	
  Portolés	
  

	
  
1.	
  INTRODUCTION	
  

        This	
   review	
   focuses	
   on	
   the	
   use	
   and	
   possible	
   applications	
   of	
  
phosphoinositide-­-3	
   kinase	
   (PI3K)-­-specific	
   inhibitors	
   to	
   modulate	
   immune	
  
responses,	
  with	
  an	
  emphasis	
  on	
  T	
  lymphocyte-­-dependent	
  adaptive	
  responses.	
  

        Phosphoinositide-­-3	
   kinases	
   (PI3Ks)	
   are	
   enzymes	
   that	
   phosphorylate	
   the	
  
OH-­-	
   group	
   at	
   the	
   D3-­-position	
   of	
   the	
   inositol	
   ring	
   of	
   inositol-­-containing	
   lipids	
  
(PtdIns)	
   located	
   in	
   inner	
   leaflet	
   of	
   membrane	
   bilayers.	
   In	
   this	
   way,	
   they	
   generate	
  
intracellular	
  phosphorylated	
  inositol	
  lipids	
  (PtdInsP)	
  that	
  serve	
  to	
  anchor	
  cytosolic	
  
enzymes	
   facilitating	
   interaction	
   with	
   their	
   substrates	
   and/or	
   their	
   activation,	
  
initiating	
   different	
   cell	
   signaling	
   cascades	
   (Figure	
   1)	
   (reviewed	
   in	
   (1-­-5)).	
   This	
   is	
  
mediated	
   by	
   membrane	
   translocation	
   of	
   different	
   effector	
   proteins	
   that	
   possess	
  
domains,	
   like	
   the	
   Pleckstrin	
   homology	
   domain	
   (PH),	
   the	
   Phox	
   homology	
   domain	
  
(PX)	
  or	
  the	
  FYVE	
  domain,	
  specific	
  for	
  distinct	
  phosphorylated	
  inositides	
  (Figure	
  1).	
  
These	
   effector	
   proteins	
   are	
   involved	
   in	
   the	
   regulation	
   of	
   many	
   essential	
   cell	
  
functions	
   including	
   cell	
   survival,	
   growth,	
   and	
   proliferation.	
   Not	
   surprisingly,	
  
different	
   signals	
   essential	
   to	
   the	
   function	
   of	
   cells	
   of	
   the	
   immune	
   system	
   activate	
  
PI3K	
  activity.	
  For	
  instance,	
  in	
  lymphocytes	
  PI3K	
  activity	
  is	
  enhanced	
  upon	
  antigen	
  
activation,	
   engagement	
   of	
   costimulatory	
   molecules,	
   binding	
   of	
   cytokines	
   or	
  
quimiokines	
   to	
   their	
   receptors,	
   or	
   integrin-­-mediated	
   adhesion.	
   Thus,	
   PI3Ks	
   are	
  
prime	
  targets	
  for	
  immunomodulatory	
  strategies.	
  

        Differences	
   in	
   protein	
   structure,	
   regulation	
   of	
   activity,	
   and	
   lipid	
   substrate	
  
preference	
   define	
   three	
   different	
   classes	
   of	
   PI3K,	
   namely	
   class	
   I,	
   class	
   II	
   and	
   class	
  
III	
  PI3K	
  (Figure	
  1,	
  2).	
  In	
  mammals	
  there	
  are	
  eight	
  different	
  PI3K	
  isoforms.	
  Of	
  them,	
  
four	
   are	
   class	
   I	
   PI3Ks	
   (p110a,	
   p110ß,	
   p110?	
   and	
   p110d),	
   three	
   belong	
   to	
   class	
   II	
  
PI3K	
  (PI3K-­-C2a,	
  PI3K-­-C2ß,	
  PI3K-­-C2?)	
  and	
  the	
  vacuolar	
  sorting	
  protein	
  34	
  (VPS34)	
  
is	
  the	
  only	
  class	
  III	
  PI3K.	
  Class	
  I	
  are	
  PI3Kinases	
  specific	
  for	
  PtdIns(4,5)P2	
  and	
  play	
  a	
  
major	
   role	
   in	
   signal	
   transduction	
   induced	
   by	
   receptors	
   that	
   activate	
   protein	
  
tyrosine	
  kinases	
  (class	
  IA	
  PI3K)	
  or	
  by	
  receptors	
  coupled	
  to	
  small	
  GTPases	
  (class	
  IB	
  
PI3K).	
   Class	
   II	
   and	
   III	
   PI3Kinases	
   phosphorylate	
   PtdIns.	
   Class	
   II	
   have	
   a	
   role	
   in	
  
signal	
  transduction,	
  but	
  many	
  aspects	
  of	
  their	
  biology	
  are	
  not	
  well	
  known;	
  Class	
  III	
  
have	
  a	
  role	
  in	
  vesicle	
  trafficking.	
  

        	
  

        	
  

        	
  

92	
  

	
  
   89   90   91   92   93   94   95   96   97   98   99